1. Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis
    Shi Tang et al, 2017, Mediators of Inflammation CrossRef
  2. Long read reference genome-free reconstruction of a full-length transcriptome from Astragalus membranaceus reveals transcript variants involved in bioactive compound biosynthesis
    Jun Li et al, 2017, Cell Discov. CrossRef
  3. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy
    Li-Jun Duan et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  4. Impact of high glucose and AGEs on cultured kidney-derived cells. Effects on cell viability, lysosomal enzymes and effectors of cell signaling pathways
    Giovani B. Peres et al, 2017, Biochimie CrossRef
  5. Long non-coding RNAs: An essential emerging field in kidney pathogenesis.
    Hakimeh Moghaddas Sani et al, 2018, Biomed Pharmacother CrossRef
  6. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway
    Huicong Li et al, 2018, European Journal of Pharmacology CrossRef
  7. An integrated strategy for extraction and pre-concentration of four astragalosides from Radix Astragali by a formulated surfactant aqueous system
    Suixin Wang et al, 2018, Journal of Industrial and Engineering Chemistry CrossRef
  8. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway
    Shan Huang et al, 2018, J Cell Physiol CrossRef
  9. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial‐to‐mesenchymal transition by targeting miR‐27b‐3p and ZEB1 in diabetic nephropathy
    Xiaowei Wang et al, 2018, J Cell Physiol CrossRef
  10. Roles of Identified Long Noncoding RNA in Diabetic Nephropathy
    Yan Li et al, 2019, Journal of Diabetes Research CrossRef
  11. Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
    Zubair Ilyas et al, 2017, Rev Endocr Metab Disord CrossRef
  12. Shenqi Jiangtang Granule Ameliorates Kidney Function by Inhibiting Apoptosis in a Diabetic Rat Model
    Qian Zhang et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
  13. Effect of astragalosides on long non-coding RNA expression profiles in rats with adjuvant-induced arthritis
    Hui Jiang et al, 2019, Int J Mol Med CrossRef
  14. Astragaloside IV ameliorates high glucose‑induced renal tubular epithelial‑mesenchymal transition by blocking mTORC1/p70S6K signaling in HK‑2 cells.
    Xiao Chen et al, 0 CrossRef
  15. Transcriptomics analysis of sirolimus treatment in lupus nephritis
    Dongdong Wang et al, 2019, Mol Med Report CrossRef
  16. Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
    Qian Zhang et al, 2021, Front. Physiol. CrossRef
  17. Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats
    Dong Han, 2021, J Int Med Res CrossRef
  18. Carbohydrate response element binding protein (ChREBP) modulates the inflammatory response of mesangial cells in response to glucose
    Yan Chen et al, 2018 CrossRef
  19. Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats
    Shaohua Li et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  20. Clean-DM1, a Korean Polyherbal Formula, Improves High Fat Diet-Induced Diabetic Symptoms in Mice by Regulating IRS/PI3K/AKT and AMPK Expressions in Pancreas and Liver Tissues
    Piao Wang et al, 2023, Chin. J. Integr. Med. CrossRef